Adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive early breast cancer: Evidence evaluation and GRADE recommendations by the Italian Association of Medical Oncology (AIOM)-Reference-Cited by-同舟云学术

Adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive early breast cancer: Evidence evaluation and GRADE recommendations by the Italian Association of Medical Oncology (AIOM)

Published:2018-08 Issue: Volume:99 Page:9-19
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Gori Stefania^ORCID,Puglisi Fabio,Cinquini Michela,Pappagallo Giovanni,Frassoldati Antonio,Biganzoli Laura,Cortesi Laura,Fiorentino Alba,Angiolini Catia,Tinterri Corrado,De Censi Andrea,Levaggi Alessia,Del Mastro Lucia

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference21 articles.

1. I numeri del cancro in Italia;AIOM-AIRTUM,2016

2. Estrogen receptor breast cancer phenotypes in the surveillance, epidemiology, and end results database;Anderson;Breast Cancer Res Treat,2002

3. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology clinical practice guideline focused update;Burstein;J Clin Oncol,2014

4. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials;Early Breast Cancer Trialists’ Collaborative Group (EBCTCG);Lancet,2011

5. American Society of Clinical Oncology endorsement of the cancer care Ontario practice guideline on adjuvant ovarian ablation in the treatment of premenopausal women with early-stage invasive breast cancer;Griggs;J Clin Oncol,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study;The Breast;2024-10

2. Low levels of sex hormone-binding globulin predict an increased breast cancer risk and its underlying molecular mechanisms;Open Life Sciences;2024-01-01

3. Adjuvant Endocrine Therapy Choices in Premenopausal Patients with Hormone Receptor-Positive Early Breast Cancer: Results from the Prospective Gim23-Poster Study;2024

4. Prevalence of a BRCA2 Pathogenic Variant in Hereditary-Breast-and-Ovarian-Cancer-Syndrome Families with Increased Risk of Pancreatic Cancer in a Restricted Italian Area;Cancers;2023-04-03

5. How to Protect Ovarian Function before and during Chemotherapy?;Journal of Clinical Medicine;2021-09-16